The U.S Food and Drug Administration said its vaccine committee would meet on December 10 to discuss the request for emergency use authorization.
According to the organization’s Head Stephen Hahn, “The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines.”
“I want to assure the American people that the FDA’s process and evaluation of the data for a potential COVID-19 vaccine will be as open and transparent as possible,” he added.
Hahn said he could not predict how long the review would take but the federal government said earlier the final green light would probably come in December.
Pfizer Chief Executive Albert Bourla called the filing “a critical milestone in our journey to deliver a COVID-19 vaccine to the world.”
The BioNTech/Pfizer shot and another one being developed by the US firm Moderna has taken the lead in the global chase for a vaccine.